Results 91 to 100 of about 57,426 (267)
Biglycan : a multivalent proteoglycan providing structure and signals [PDF]
Research over the past few years has provided fascinating results indicating that biglycan, besides being a ubiquitous structural component of the extracellular matrix (ECM), may act as a signaling molecule.
Năstase, Mădălina-Viviana +2 more
core
BackgroundMuscular dystrophies and congenital myopathies encompass various inherited muscular disorders that present diagnostic challenges due to clinical complexity and genetic heterogeneity.MethodsThis study aimed to investigate the use of whole exome ...
Chung-Lin Lee +22 more
doaj +1 more source
LARGE expression in different types of muscular dystrophies other than dystroglycanopathy
Background Alpha-dystroglycan (αDG) is an extracellular peripheral glycoprotein that acts as a receptor for both extracellular matrix proteins containing laminin globular domains and certain arenaviruses.
Burcu Balci-Hayta +3 more
doaj +1 more source
Dupuytren's Contracture Cosegregation with Limb-Girdle Muscle Dystrophy
Limb-girdle muscular dystrophies (LGMDs) is a heterogeneous group of muscular dystrophies that mostly affect the pelvic and shoulder girdle muscle groups.
Baiba Lace +7 more
doaj +1 more source
Degree of Cajal-Retzius cell mislocalisation correlates with the severity of structural brain defects in mouse models of dystroglycanopathy [PDF]
The secondary dystroglycanopathies are characterized by the hypoglycosylation of alpha dystroglycan, and are associated with mutations in at least 18 genes that act on the glycosylation of this cell surface receptor rather than the Dag1 gene itself.
Booler, H +3 more
core +1 more source
Background Dystrophin-glycoprotein complex (DGC)-related muscular dystrophies may present similar clinical and pathological features as well as undetectable mutations thus being sometimes difficult to distinguish.
Zhiying Xie +11 more
doaj +1 more source
Assessment of the Use of Non-Pharmacological Methods for Managing Depression in Patients with Myotonic Dystrophy (DM) and Facioscapulohumeral Muscular Dystrophy (FSHD) [PDF]
Background: Myotonic dystrophy (DM) and facioscapulohumeral muscular dystrophy (FSHD) are two types of muscular dystrophies with multi-system manifestations.
Miller, Kimberly +3 more
core +1 more source
Systemic AAV Micro-dystrophin Gene Therapy for Duchenne Muscular Dystrophy [PDF]
Dongsheng Duan
openalex +1 more source
Special Issue—Towards Understanding the Mechanisms and Curing of Muscular Dystrophy Diseases
Muscular dystrophies are a heterogeneous group of inherited diseases with different molecular basss, but sharing similar clinical features and dystrophic changes.
Leonidas A. Phylactou
doaj +1 more source

